Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Talimogene Laherparapvec ×

Talimogene Laherparapvec

This drug is selected. Its supporting articles are shown below.

Talimogene Laherparapvec1

Articles mentioning Talimogene Laherparapvec

1 articles · page 1 of 1

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response

jitc · abstract · 2025-11-04 · 2 matching annotations

94.5%

Talimogene laherparepvec talimogene laherparapvec pembrolizumab B16F10 melanoma Massachusetts General Hospital MGH

…Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Talimogene laherparepvec improves durable respose rate in patients with advanced melanom…

Browse drugs

Talimogene Laherparapvec

Articles mentioning Talimogene Laherparapvec

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response